Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07581379 · ClinicalTrials.gov registry record
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations
A clinical trial, sponsored by University of Florida.
- Active
- Registry status
- 1,826
- Enrollment target
NCT07581379: Active study, sponsored by University of Florida.
NCT07581379 is a clinical trial that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 1,826 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07581379 is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- 1,826 participants
- Enrollment target
Study Summary
This observational study evaluates the effectiveness of computed tomography (CT) imaging surveillance after curative-intent treatment for stage I-IIIA non-small cell lung cancer (NSCLC) in a diverse U.S. population. The main questions are: How do CT surveillance use and adherence vary by race, ethnicity, and socioeconomic status? Does semi-annual CT surveillance improve outcomes compared with annual surveillance? Adults ages 20-90 with stage I-IIIA NSCLC treated between 2012 and 2026 will be identified using OneFlorida+ electronic health records, tumor registry data, claims, and clinical notes. Patients will be followed for up to five years after curative-intent therapy to evaluate surveillance patterns, recurrence, second primary lung cancers, complications, and survival.
Primary Outcome
Proportion of patients who complete guideline-recommended post-treatment chest CT surveillance within prespecified rolling surveillance windows. Guideline adherence will be defined using ±1-month and ±2-month allowable windows around each recommended surveillance time point. Semi-annual surveillance (Years 0-2) will be assessed at recommended months 6, 12, 18, and 24, with adherence defined as completing a CT within months 5-7 or 4-8, 11-13 or 10-14, 17-19 or 16-20, and 23-25 or 22-26, respectiv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,826 participants |
| Start Date | 2012-01 |
| Est. Completion | 2026-12 |
What the registry record for NCT07581379 still lists
NCT07581379 is an observational study that tracks outcomes without assigning an intervention. Its 1,826 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT07581379 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07581379 about?
NCT07581379 is a clinical study titled "Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations". This observational study evaluates the effectiveness of computed tomography (CT) imaging surveillance after curative-intent treatment for stage I-IIIA non-small cell lung cancer (NSCLC) in a diverse U.S. population. The main questions are: How do CT surveillance use and adherence vary by race, eth...
What is the current status of trial NCT07581379?
This trial is currently active not recruiting. The enrollment target is 1,826 participants. The study started on 2012-01. Estimated completion is 2026-12.
Who is sponsoring clinical trial NCT07581379?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia